Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine

Circulation Research

Volumn 77, Issue 6, 1995, Pages 1136-1142

  Bennett, M R ^a,b,c   Gibson, D F ^a   Schwartz, S M ^a   Tait, J F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

annexin V; apoptosis; phagocytosis; phosphatidylserine; vascular smooth muscle

Indexed keywords

EDETIC ACID; LIPOCORTIN 5; LIPOSOME; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL KINETICS; CONTROLLED STUDY; DOSE RESPONSE; ETIOLOGY; INHIBITION KINETICS; NONHUMAN; ONCOGENE C MYB; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0028788202     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.77.6.1136     Document Type: Article

References (47)

1. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194-1200.
2. Araki S, Simada Y, Kaji K, Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun. 1990; 172:1081-1085.
3. Bennett MR, Evan GI, Newby AC. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994; 74-.525-536.
4. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
5. Geng Y, Libby P. Evidence for apoptosis in advanced human atheroma; colocalization with interleukin-1β converting enzyme. Am J Pathol. 1995;147:251-266.
6. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherosclerosis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
7. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
8. Morris RG, Hargreaves AD, Duvall E, Wyllie AH. Hormone-induced cell death, 2: surface changes in thymocytes undergoing apoptosis. Am J Pathol. 1984;115:426-436.
9. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology. 1985; 56:351-358.
10. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 1992;296:174-178.
11. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature. 1990; 343:170-173.
12. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol. 1992; 149:4029-4035.
13. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol. 1994;153:3218-3227.
14. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207-2216.
15. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM. Pals ST. van Oers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415-1420.
16. Tait JF, Smith C. Site-specific mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipid binding. Arch Biochem Biophys. 1991;288:141-144.
17. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med. 1994;123:741-748.
18. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem. 1989;264:7944-7949.
19. Morgenstern J, Land H. Choice and manipulation of retroviral vectors. In: Murray EJ, ed. Gene Transfer and Expression Protocols. Clifton, NJ: Humana Press Inc; 1991:181-206.
20. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995;77:266-273.
21. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102:344-352.
22. Fadok VA, Laszlo DJ, Noble PW, Weinstein L, Riches DW, Henson PM. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol. 1993;151: 4274-4285.
23. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets: evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem. 1990;265:17420-17423.
24. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem. 1991;266:24302-24307.
25. Homburg CHE, de Haas M, von dem Borne AEG, Verhoeven AJ, Reutelingsperger CPM, Roos D. Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood. 1995;85:532-540.
26. Nakamura N, Shidara Y, Kawaguchi N, Azuma C, Mitsuda N, Onishi S, Yamaji K, Wada Y. Lupus anticoagulant autoantihody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem Biophys Res Commun. 1994;205:1488-1493.
27. Henson PM, Johnston RBJ. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest. 1987;79: 669-674.
28. Rao LV, Tait JF, Hoang AD. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008): contrasting effects on cell surface factor Vila/tissue factor activity and prothrombinase activity. Thromb Res. 1992;67:517-531.
29. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A. 1995;92:1396-1400.
30. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest. 1985;75:1965-1972.
31. Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem. 1985;260:5131-5138.
32. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 1991;51:3062-3066.
33. Allen TM, Williamson P, Schlegel RA. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A. 1988;85: 8067-8071.
34. Nishikawa K, Arai H, Inoue K. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem. 1990;265: 5226-5231.
35. Lee KD, Pitas RE, Papahadjopoulos D. Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim Biophys Acta. 1992;1111:1-6.
36. Sambrano GR, Parthasarathy S, Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:3265-3269.
37. Ottnad E, Parthasarathy S, Sambrano GR, Ramprasad MP, Quehenberger O, Kondratenko N, Green S, Steinberg D. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A. 1995;92:1391-1395.
38. Schroit A, Zwaal R. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochem Biophys Acta. 1991;1071: 313-329.
39. Devaux P, Zachowski A. Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids. 1994;73: 107-120.
40. Morrot G, Zachowski A, Devaux PF. Partial purification and characterization of the human erythrocyte Mg2(+)-ATPase: a candidate aminophospholipid translocase. FEBS Lett. 1990;266:29-32.
41. Geldwerth D, Kuypers FA, Butikofer P, Allary M, Lubin BH, Devaux PF. Transbilayer mobility and distribution of red cell phospholipids during storage. J Clin Invest. 1993;92:308-314.
42. Herrmann A, Devaux PF. Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim Biophys Acta. 1990;1027:41-46.
43. Connor J, Gillum K. Schroit AJ. Maintenance of lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. Biochim Biophys Acta. 1990;1025:82-86.
44. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry. 1992;31:6355-6360.
45. Sulpice JC, Zachowski A, Devaux PF, Giraud F. Requirement for phosphatidylinositol 4,5-bisphosphatc in the Ca(2+)-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem. 1994;269:6347-6354.
46. Smeets EF, Comfurius P, Bevers EM, Zwaal RF. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta. 1994;1195:281-286.
47. McConkey DJ, Hartzell P, Amador PJF, Orrenius S, Jondal M. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol. 1989;143: 1801-1806.